How to submit your paper
Authors' contributions and signatures
Conflict of interest and source of funding
The content of CANNABINOIDS
How CANNABINOIDS handles your paper
What happens after publication?
Articles to CANNABINOIDS should be submitted in English online to the following address: firstname.lastname@example.org
First submissions to CANNABINOIDS should include:
- Manuscript, including tables and figures
- Authors' contributions statement (see next section)
- Conflict of interest and source of funding statements (see next section)
All texts should be written in English. The submission should comprise only one Microsoft Word file containing all the material (main text, figures/illustrations, scanned photographs, tables, chemical structures). Figures, tables and all other material should be embedded in the file. Authors are required to proofread their manuscript before submission. The Publisher will not be responsible for any error occurring in the manuscript in this regard.
Should your paper be selected for further consideration we will then ask you to send signed copies of the following statements:
- Authors' contributions
- Conflicts of interest
We ask all authors of, and all contributors to articles to specify their individual contributions at the end of the text. We suggest the following format for Articles: "I declare that I participated in the (here list contributions made to the study) and that I have seen and approved the final version. I have the following conflicts of interest" (list here all relevant conflicts; see Conflict of interest and source of funding). A similar format can be used for other types of submission. At the external peer review stage we will ask you to send us signed copies of these statements for all authors. These signatures need not be dated.
A conflict of interest exists when an author or the author's institution has financial or personal relationships with other people or organisations that inappropriately influence (bias) his or her actions. Financial relationships are easily identifiable, but conflicts can also occur because of personal relationships, academic competition, or intellectual passion. A conflict can be actual or potential, and full disclosure to the Publisher is the safest course. All submissions to CANNABINOIDS must include disclosure of all relationships that could be viewed as presenting a potential conflict of interest. The Editor may use such information as a basis for editorial decisions, and will publish such disclosures if they are believed to be important to readers in judging the manuscript.
Conflict of interest statements for authors
The corresponding author should state that he or she had full access to all the data in the study and had final responsibility for the decision to submit for publication. At the end of the text, under a subheading "Conflict of interest statement", all authors must disclose any financial and personal relationships with other people or organisations that could inappropriately influence (bias) their work. Examples of financial conflicts include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications, and travel grants, all within 3 years of beginning the work submitted. If there are no conflicts of interest, authors should state that there are none.
Role of the funding source
All sources of funding should be declared as an acknowledgment at the end of the text.
The journal will mainly consist of mini-reviews, comments and letters to the editor. Papers that do not fall into these categories (such as book reviews and original articles) are also welcome. Articles for the journal, except letters to the editor and articles on original research, are usually commissioned, but suggestions are welcome. Please contact the editor at email@example.com with a brief overview if you wish to publish in CANNABINOIDS before writing a mini-review, comment, book review, etc.
Mini-reviews cover topics of interest and comprise about 5,000 to 15,000 characters (excluding references), no more than 50 references and a 200-word unstructured summary. Mini-reviews give a short and up-to-date overview of important recent medical/scientific findings, ideas or issues. They should be written in a form understandable by the generalist.
Comments on someone else's paper or other report published elsewhere within the past month or so, or on an event in the near future comprise about 5,000-10,000 characters and 10 or so references. Comments should contain a 200-word unstructured summary. We will also consider longer or shorter Comments.
Letters to the editor
We welcome correspondence on what we have published in CANNABINOIDS. Letters to be considered for publication must reach us within 4 weeks of publication of the original item and should be no longer than 1,000 characters. Letters of general interest, unlinked to earlier items in the journal, are also considered, and can be up to 2,000 characters long. Longer letters may be considered for publication, but the editor should be contacted to discuss the reason, why a letter will exceed the usual maximum length. Correspondence letters are not usually peer reviewed, but the journal may invite replies from the authors of the original publication, or pass on letters to these authors. There should be no more than five references and five authors. The corresponding author's signature will be sought at this stage and is taken to be a signature provided on behalf of all authors.
Articles on original research
CANNABINOIDS does not give priority to reports of original research, but welcomes such articles. Publication of original research may be of interest for authors if the target readership are people interested in the medical use of cannabis and/or cannabinoids and related issues, and if a considerable part of the target readership does not read English. Articles on original research should contain a 250-word unstructured summary.
Articles of the Month
Articles of the Month are chosen by the Editorial Board and usually written by members of the Editorial Board but also by invited authors on important articles published recently in other journals. These articles will briefly report on an important publication in another journal with relevance to the medical use of cannabis and cannabinoids. The Article of the Month will serve as a complement to the IACM-Bulletin, and will not only report on new research results (as does the IACM-Bulletin), but also put the new results into a context of earlier research and may include a comment. Articles will be short (1000 to 1500 words) with no more than five to ten references.
Other formats that may be considered for publication in CANNABINOIDS are Case Reports, Book Reviews, Viewpoints and articles on Medical History. Case Reports describe, in 2,500 characters, a single interesting case, which should not be a rarity but one that a general physician might encounter, and that provides a teaching point.
The manuscript should be divided as: Title page, abstract and the main text. The text may be subdivided further according to the areas to be discussed. This should be followed by the Acknowledgement (if any) and Reference sections. The first page should contain the title, the authors' names (forename and surname), with an asterisk in front of the name of the principal author. The first page should also contain the address, phone and fax number as well as e-mail address of the principal author.
The abstracts should not exceed 200-250 words depending on kind of article and it should condense the essential findings and conclusions.
Authors must supply up to eight key words along with their manuscript.
The main text should begin on a separate page and it may be subdivided into separate sections. Acknowledgements should be kept to a minimum.
- Data Tables should be submitted in Microsoft Word table format.
- Each table should include a title/caption explaining what the table shows. Detailed legends may then follow.
- Tables should be given on separate pages with indications in the text, as to the appropriate placement of the tables as follows: [Table 1 here].
- Columns and rows of data should be made visibly distinct by ensuring the borders of each cell display as black lines.
- Tables must fit a single or double column format on the journal page. A single column has a width of 8.0 cm, a double column a width of 17.0 cm. Maximum height for tables is 24.0 cm.
- Font: Times New Roman or Helvetica is preferable. Font size: 10pt (maximum).
- Tables should be numbered consecutively in order of their citation in the body of the text, with Arabic numerals. Tables should be referred to as (Table 1), (Table 2) etc. in the text.
Figures / Illustrations
The quality of the illustrations presented online or printed in the journal largely depends on the quality of the figures/illustration provided by the author. In preparing artwork or graphics for publication, keep in mind the following points.
Submit the original figure or illustration embedded in the MS Word file of the manuscript.
Remove all colour from graphics except for those illustrations (Greyscale), which are intended to be printed in colour.
Figures/illustrations cannot be modified or enhanced by the journal.
Figures should be referred to as (Figure 1), (Figure 2) etc. in the text.
Illustrations must fit a single or double column format on the journal page. A single column has a width of 8.0 cm, a double column a width of 17.0 cm. Maximum height for illustrations is 24.0 cm.
Avoid textures and shadings giving a three-dimensional effect to the illustration.
Symbols and lettering in the illustration should be of similar size.
Font: Times New Roman or Helvetica is preferable. Font size: 10pt (maximum).
Line drawings should have clear and sharp lines and should be of uniform density. Moreover, lines should be continuous without any breaks.
Do not use lines thinner than 1 point.
The reference numbers in normal font should be given in square brackets in the text (e.g. ), then collected at the end of the manuscript in alphabetical order.
For the format of references the Vancouver Style, or Uniform Requirements Style, should be used. Examples are presented below. All authors should be listed. Extended examples for this style are available in the internet here.
Standard journal article
Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347(4):284-7.
Organization as author of a journal article
Diabetes Prevention Program Research Group. Hypertension, insulin, and proinsulin in participants with impaired glucose tolerance. Hypertension. 2002;40(5):679-86.
Article not in English
Ellingsen AE, Wilhelmsen I. Sykdomsangst blant medisin- og jusstudenter. Tidsskr Nor Laegeforen. 2002;122(8):785-7.
Books with personal author(s)
Murray PR, Rosenthal KS, Kobayashi GS, Pfaller MA. Medical microbiology. 4th ed. St. Louis: Mosby; 2002.
Editor(s) as author
Gilstrap LC 3rd, Cunningham FG, VanDorsten JP, editors. Operative obstetrics. 2nd ed. New York: McGraw-Hill; 2002.
Chapter in a book
Meltzer PS, Kallioniemi A, Trent JM. Chromosome alterations in human solid tumors. In: Vogelstein B, Kinzler KW, editors. The genetic basis of human cancer. New York: McGraw-Hill; 2002. p. 93-113.
Christensen S, Oppacher F. An analysis of Koza's computational effort statistic for genetic programming. In: Foster JA, Lutton E, Miller J, Ryan C, Tettamanzi AG, editors. Genetic programming. EuroGP 2002: Proceedings of the 5th European Conference on Genetic Programming; 2002 Apr 3-5; Kinsdale, Ireland. Berlin: Springer; 2002. p. 182-91.
Tynan T. Medical improvements lower homicide rate: study sees drop in assault rate. The Washington Post. 2002 Aug 12;Sect. A:2 (col. 4).
Articles will usually be published online within 4 weeks of receipt of the manuscript.
Receipt of your paper will be acknowledged by email usually within 24-48 h.
Usually every Article on Original Research, every Comment, Case Report, Mini-Review, and Medical History article that is submitted will be peer reviewed. Occasionally contributions will be accepted without peer review. Your report will first be read by the editor. If your article is regarded as suitable for publication in CANNABINOIDS it will be peer-reviewed by at least two reviewers.
Submissions might be referred back to authors for revision. Two copies of the revised version should be sent back, one of which should be highlighted to show where changes have been made. Detailed responses to reviewers' comments, in a covering letter, are necessary too.
After acceptance your article will be laid out. You will receive a proof. That proof should be corrected and returned within 48 hours.
Translation into other languages
Your article will be translated into other languages. So far, the translation into German and Spanish are guaranteed. Translation into French, Italian and Dutch may follow.
Announcement in the IACM-Bulletin
The publication of your article on the IACM Website will be announced in the IACM-Bulletin. The IACM-Bulletin is an online newsletter published in six languages with more than 5,000 subscribers.
You will receive a PDF file of your article.
Authors will be asked to sign a transfer of copyright agreement, which recognises the common interest that both journal and author(s) have in the protection of copyright. Please note that the policy of CANNABINOIDS allows that online published articles can be downloaded, printed and distributed freely for any non-commercial purposes, provided the original work is properly cited.
IACM Conference 2013
7th Conference on Cannabinoids in Medicine
27-28 September 2013
Holiday Inn, Cologne, Germany.
6th European Workshop on Cannabinoids
18-20 April 2013
Trinity College Dublin, Ireland
The University of British Columbia in partnership with the ICRS and the CCIC will organize “Cannabinoids in Clinical Practice” on 21 June 2013, a full day continuing medical education (CME) event.